Form 4 holding
Chief Financial Officer
CytoMed Therapeutics Ltd
- Security class
- Ordinary Shares, no par value per share
- Shares / value
- 25,781
- Estimated value
- $24,234
- Report date
- 18 Mar 2026
- Price
- $0.9400
- Ownership
- Direct